Home Disruptive Innovations Shaping the Future of Adoptive Cell Therapies

The therapeutic potential of cell therapies is an established fact, but whether will they be able to overcome challenges posed by Solid Tumors remains a question. With innovative strategies, many types of cell therapies are being developed by Industry and academia with a focus on succeeding in Solid tumors. Engineered receptors (like CAR/ TCR), novel gene-editing techniques (CRISPR/ Transposons/ lentiviral, etc), scaling processes, etc are being developed to actualize the dream of transforming patients’ treatment through cell therapies.

Let’s explore the upcoming disruptive innovations that will bring about a paradigm shift in the development and success of cell therapies in solid tumors.

FutureBridge’s Oncology Analysts in this webinar cover:

  • Residual unmet needs that are unlikely to be answered by upcoming platforms
  • The focus of current innovations on improving cell therapies
  • What innovation trend is driving the technological reform in cell therapies?
  • Reproducible quick manufacturing and scaling platforms of cell therapies
  • Innovative platforms that hold the potential to push cell therapy toward success in Solid Tumors
  • FutureBridge’s vision and take on industry transformation

Need a thought partner?

Share your focus area or question to engage with our Analysts through the Business Objectives service.

Submit My Business Objective

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.